PKOH - Park Ohio Holdings Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Park ohio Holdings Corp (PKOH)

Other Ticker:

Sector • Basic Materials Industry • Miscellaneous Fabricated Products

Industry • Miscellaneous Fabricated Products

Sector • Basic Materials

Price: $16.1600 $0.18

1.126%

Day's High:	$16.16	Week Perf:	9.26 %
Day's Low:	$ 15.77	30 Day Perf:	8.09 %
Volume (M):	31	52 Wk High:	$ 36.11
Volume (M$):	$ 503	52 Wk Avg:	$24.21
Open:	$15.77	52 Wk Low:	$10.78

PKOH Charts & Quotes

PKOH Charts & Quotes

Description of Company's Segments

Market Capitalization (Millions $)	196
Shares Outstanding (Millions)	12
Employees	600
Revenues (TTM) (Millions $)	1,378
Net Income (TTM) (Millions $)	5
Cash Flow (TTM) (Millions $)	-4
Capital Exp. (TTM) (Millions $)	29

Park Ohio Holdings Corp
Park-Ohio Holdings Corp., incorporated in Ohio since 1998, is a diversified international company providing world-class customers with a supply chain management outsourcing service, capital equipment used on their production lines, and manufactured components used to assemble their products.

Company Address: 6065 Parkland Boulevard, Cleveland, 44124 OH
Company Phone Number: 947-2000 Stock Exchange / Ticker: NASDAQ PKOH

PKOH is expected to report next financial results on November 06, 2020.

Park Ohio Holdings's Segments

• View Complete Report

News

Lipocine Inc

Redemption of Losses,

In the second quarter Lipocine Inc decreased loss at $-0.13 per share, compared to results of $-0.14 per share a year ago quarter, In the previous quarter company realized $-0.14 per share.

Innodata Inc

Loss Despite Sales Growth

Innodata Inc announced earnings per share of $-0.02 and Sales of $14.53 millions in the second quarter, Company's lost money per share, versus $-0.03 eps, earned in the same quarter a year ago, although Innodata Inc saw it's Sales rise by 1.64% in the same period.

Applied Dna Sciences Inc

Applied Dna Sciences Inc announced third quarter operating deficit of $-3.188794 millions

Applied Dna Sciences Inc reported disastrous third quarter, where Sales faded by -78.99% to $0.43 millions and loss per share has widen to $-0.72, from the same quarter a year ago.

Eyegate Pharmaceuticals Inc

Deficit Bigger Than a Year Ago but Revenues Unchanged

In the second quarter Eyegate Pharmaceuticals Inc loss increased of $-0.38 per share compared to $-0.04 a year ago and improved from $-0.43 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Celldex Therapeutics Inc

Rasults hit by impairment charges

Celldex Therapeutics Inc see it's second quarter results, effected by $3.50 million impairment of assets, company reports $-0.50 loss per share.

PKOH's Valuation	Current
Price to Earnings PE Ratio (TTM)	50.50
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	0.14
Price to Sales (Expected)	-
Price to Book	0.62
PEG (TTM)	-

PKOH's Financial Strength	Current
Quick Ratio	0.21
Working Capital Ratio	2.68
Leverage Ratio (MRQ)	2.91
Total Debt to Equity	1.75
Interest Coverage (TTM)	2.3
Debt Coverage (TTM)	0.13

Per Share	Current
Earnings (TTM)	0.32 $
Revenues (TTM)	113.84 $
Cash Flow (TTM)	-0.31 $
Cash	4.29 $
Book Value	26.13 $
Dividend (TTM)	1.36 $

PKOH's Efficiency	Current
Revenue per Employee (TTM)	2,295,833
Net Income per Employee (TTM)	7,833
Receivable Turnover Ratio (TTM)	5.56
Inventory Turnover Ratio (TTM)	3.64
Asset Turnover Ratio (TTM)	1.05

PKOH's Profitability Ratio	Current
Gross Margin	6.22 %
Operating Margin	-
Net Margin	-
Net Cash Flow Margin	0.44 %
Effective Tax Rate (TTM)	-

Management Effectiveness	Current
Return On Assets (TTM)	0.36 %
Return On Investment (TTM)	0.47 %
Return On Equity (TTM)	1.41 %
Dividend Yield	5.92 %
Payout Ratio (TTM)	425 %

PKOH's Valuation
Price to Earnings PE Ratio (TTM)	50.50
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	0.14
Price to Sales (Expected)	-
Price to Book	0.62
PEG (TTM)	-

PKOH's Financial Strength
Quick Ratio	0.21
Working Capital Ratio	2.68
Leverage Ratio (MRQ)	2.91
Total Debt to Equity	1.75
Interest Coverage (TTM)	2.3
Debt Coverage (TTM)	0.13

Per Share
Earnings (TTM)	0.32 $
Revenues (TTM)	113.84 $
Cash Flow (TTM)	-0.31 $
Cash	4.29 $
Book Value	26.13 $
Dividend (TTM)	1.36 $

• View Valuation Comparisons

• View Growth Rates Comparisons

PKOH's Efficiency
Revenue per Employee (TTM)	2,295,833
Net Income per Employee (TTM)	7,833
Receivable Turnover Ratio (TTM)	5.56
Inventory Turnover Ratio (TTM)	3.64
Asset Turnover Ratio (TTM)	1.05

PKOH's Profitability Ratio
Gross Margin	6.22 %
Operating Margin	-
Net Margin	-
Net Cash Flow Margin	0.44 %
Effective Tax Rate (TTM)	-

Management Effectiveness
Return On Assets (TTM)	0.36 %
Return On Investment (TTM)	0.47 %
Return On Equity (TTM)	1.41 %
Dividend Yield	5.92 %
Payout Ratio (TTM)	425 %

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income grew by	PKOH's customers Net margin grew to
9.68 %	3.87 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

RELL		2.31%
SANM		1.08%
SMTX		3.83%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar LORL's Profile Stock Price LORL's Financials Business Description Fundamentals Charts & Quotes LORL's News Suppliers LORL's Competitors Customers & Markets Economic Indicators LORL's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

PKOH Company Profile

Redemption of Losses,

Loss Despite Sales Growth

Applied Dna Sciences Inc announced third quarter operating deficit of $-3.188794 millions

Deficit Bigger Than a Year Ago but Revenues Unchanged

Rasults hit by impairment charges